269 related articles for article (PubMed ID: 33523792)
1. The Usefulness of Pretreatment MR-Based Radiomics on Early Response of Neoadjuvant Chemotherapy in Patients With Locally Advanced Nasopharyngeal Carcinoma.
Yongfeng P; Chuner J; Lei W; Fengqin Y; Zhimin Y; Zhenfu F; Haitao J; Yangming J; Fangzheng W
Oncol Res; 2021 Mar; 28(6):605-613. PubMed ID: 33523792
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma.
Mao J; Fang J; Duan X; Yang Z; Cao M; Zhang F; Lu L; Zhang X; Wu X; Ding Y; Shen J
Eur Radiol; 2019 Aug; 29(8):4105-4113. PubMed ID: 30617473
[TBL] [Abstract][Full Text] [Related]
4. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
[TBL] [Abstract][Full Text] [Related]
5. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma.
Cao X; Wang X; Song J; Su Y; Wang L; Yin Y
BMC Cancer; 2024 Apr; 24(1):435. PubMed ID: 38589858
[TBL] [Abstract][Full Text] [Related]
7. Intravoxel Incoherent Motion-Magnetic Resonance Imaging as an Early Predictor of Treatment Response to Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
Xiao Y; Pan J; Chen Y; Chen Y; He Z; Zheng X
Medicine (Baltimore); 2015 Jun; 94(24):e973. PubMed ID: 26091468
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
9. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
[No Abstract] [Full Text] [Related]
10. MRI-Based Back Propagation Neural Network Model as a Powerful Tool for Predicting the Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
Liao H; Chen X; Lu S; Jin G; Pei W; Li Y; Wei Y; Huang X; Wang C; Liang X; Bao H; Liu L; Su D
J Magn Reson Imaging; 2022 Aug; 56(2):547-559. PubMed ID: 34970824
[TBL] [Abstract][Full Text] [Related]
11. Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma.
Liu J; Mao Y; Li Z; Zhang D; Zhang Z; Hao S; Li B
J Magn Reson Imaging; 2016 Aug; 44(2):445-55. PubMed ID: 26778191
[TBL] [Abstract][Full Text] [Related]
12. Diffusion kurtosis imaging predicts neoadjuvant chemotherapy responses within 4 days in advanced nasopharyngeal carcinoma patients.
Chen Y; Ren W; Zheng D; Zhong J; Liu X; Yue Q; Liu M; Xiao Y; Chen W; Chan Q; Pan J
J Magn Reson Imaging; 2015 Nov; 42(5):1354-61. PubMed ID: 25873208
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma.
Wang M; Xi Y; Wang L; Chen H; Jiang F; Ding Z
Radiat Oncol; 2024 Feb; 19(1):26. PubMed ID: 38418994
[TBL] [Abstract][Full Text] [Related]
14. Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatment.
Bao D; Liu Z; Geng Y; Li L; Xu H; Zhang Y; Hu L; Zhao X; Zhao Y; Luo D
Cancer Imaging; 2022 Jan; 22(1):10. PubMed ID: 35090572
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study.
Zhang L; Dong D; Li H; Tian J; Ouyang F; Mo X; Zhang B; Luo X; Lian Z; Pei S; Dong Y; Huang W; Liang C; Liu J; Zhang S
EBioMedicine; 2019 Feb; 40():327-335. PubMed ID: 30642750
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment MRI-Derived Radiomics May Evaluate the Response of Different Induction Chemotherapy Regimens in Locally advanced Nasopharyngeal Carcinoma.
Zhang L; Ye Z; Ruan L; Jiang M
Acad Radiol; 2020 Dec; 27(12):1655-1664. PubMed ID: 33004261
[TBL] [Abstract][Full Text] [Related]
17. Treatment Response Prediction of Nasopharyngeal Carcinoma Based on Histogram Analysis of Diffusional Kurtosis Imaging.
Tu N; Zhong Y; Wang X; Xing F; Chen L; Wu G
AJNR Am J Neuroradiol; 2019 Feb; 40(2):326-333. PubMed ID: 30630832
[TBL] [Abstract][Full Text] [Related]
18. Performance of Pretreatment MRI-Based Radiomics in Recombinant Human Endostatin Plus Concurrent Chemoradiotherapy Response Prediction in Nasopharyngeal Carcinoma: A Retrospective Study.
Huang L; Yang Z; Kang M; Ren H; Jiang M; Tang C; Hu Y; Shen M; Lin H; Long L
Technol Cancer Res Treat; 2023; 22():15330338231160619. PubMed ID: 37094106
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Setakornnukul J; Thephamongkhol K
BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma.
Zhang LL; Huang MY; Li Y; Liang JH; Gao TS; Deng B; Yao JJ; Lin L; Chen FP; Huang XD; Kou J; Li CF; Xie CM; Lu Y; Sun Y
EBioMedicine; 2019 Apr; 42():270-280. PubMed ID: 30928358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
